165 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

OCUP

Ocuphire Pharma
US$1.68-4.5%-54.1%US$43.6mUS$19.33PS2.3xE51.0%n/a

EYEN

Eyenovia
US$0.766.9%-73.5%US$43.5mUS$9.00PS4665.5xE31.1%n/a

MSCL

Satellos Bioscience
CA$0.515.2%-12.1%CA$57.5mCA$1.20PB1.7xE-13.9%n/a

IMRX

Immuneering
US$1.38-0.7%-83.8%US$41.2mUS$13.71PB0.5xE-10.9%n/a

SBBC

Simply Better Brands
CA$0.640%50.6%CA$55.5mn/aPE-1.8xn/an/a

C4XD

C4X Discovery Holdings
UK£0.1245.9%-16.4%UK£30.3mn/aPE2.9xE-88.3%n/a

DTC

Defence Therapeutics
CA$1.10-6.0%-57.9%CA$50.5mn/aPE-3.7xn/an/a

OCX

OncoCyte
US$2.70-4.6%-37.2%US$36.6mUS$4.06PS26.1xE33.5%n/a

SHWZ

Medicine Man Technologies
US$0.42-10.0%-59.0%US$36.1mUS$2.66PB0.3xS5.6%n/a

ACE

Ascelia Pharma
kr11.0422.7%-31.0%kr372.7mkr17.25PB5.9xE12.6%n/a

MVIR

Medivir
kr3.2019.4%-56.7%kr358.5mkr20.62PS46.4xE37.9%n/a

AURX

Nuo Therapeutics
US$0.75-3.8%-50.7%US$33.2mn/aPS42.4xn/an/a

BCT

BriaCell Therapeutics
CA$2.097.7%-75.3%CA$41.9mn/aPE-2.2xE-24.8%n/a

SPL

Starpharma Holdings
AU$0.11-4.3%-70.7%AU$45.3mn/aPS4.3xn/an/a

IPA

ImmunoPrecise Antibodies
US$1.09-1.8%-65.7%US$29.2mUS$7.00PS1.7xE58.2%n/a

SMSLIFE

SMS Lifesciences India
₹774.3011.2%49.0%₹2.3bn/aPE47.8xn/a0.2%

ONCT

Oncternal Therapeutics
US$8.78-4.7%42.2%US$27.3mUS$27.67PS22.6xE-13.1%n/a

APRE

Aprea Therapeutics
US$4.75-10.4%33.8%US$25.9mUS$15.67PS26.8xE7.7%n/a

MVP

Medical Developments International
AU$0.413.8%-47.8%AU$35.4mAU$3.66PS1.1xE82.7%0%

PEHA

Phapros
Rp440.00-9.1%-36.2%Rp371.3bn/aPE62xn/a3.0%

524572

Pharmaids Pharmaceuticals
₹52.68-11.7%75.6%₹1.9bn/aPS11.6xn/an/a

NANOV

Nordic Nanovector
kr2.00-18.3%-22.2%kr231.8mn/aPB3.6xn/an/a

AVCN

Avicanna
CA$0.260%-17.7%CA$25.4mn/aPS1.1xn/an/a

AIM

AIM ImmunoTech
US$0.35-8.3%-21.6%US$18.6mUS$3.58PS93.8xE6.3%n/a
Page 5 of 7
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.